COVID-19 Viral Genome Analysis Pipeline COVID-19 Viral Genome Analysis Pipeline home COVID-19 Viral Genome Analysis Pipeline home
COVID-19 Viral Genome Analysis Pipeline
Enabled by data from   gisaid-logo


This website provides analyses and tools for exploring accruing mutations in hCoV-19 (SARS-CoV-2) geographically and over time, with an emphasis on the Spike protein, using data from GISAID.

The SARS-CoV-2 sequence data used for these analyses was updated from GISAID on Nov 20, 2020

The analyses provided are based on a trimmed full length SARS-CoV-2 alignment containing 126,551 sequences:
sequence names and ID numbers used for full-length analyses,
or on a Spike alignment containing 169,256 sequences:
sequence names and ID numbers used for spike-only analyses.

The details of the analyses are described in:
Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus.
Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, de Silva TI*, McDanal C, Perez LG, Tang H, Moon-Walker A, Whelan SP, LaBranche CC, Saphire EO, and Montefiori DC.
*on behalf of the Sheffield COVID-19 Genomics Group
Cell, June 2020
DOI:10.1016/j.cell.2020.06.043

News

Nov 16, 2020
We have added a bunch of new antibody features to the Variantion Summaries spreadsheet and updated it.

Nov 9, 2020
The slides of a talk given Nov. 5, 2020 as part of the IEDB annual workshop are available. The slides describe the data included at cov.lanl.gov, and an example of how to use the analyses tools provided at this web site.

Nov 3, 2020
We have released an updated summary of SARS-CoV-2 variation.

See more

 






Acknowledgements

We gratefully acknowledge the authors, originating and submitting laboratories of the sequences from GISAID on which this research is based. The original data are available from https://www.gisaid.org

This COVID-19 response analysis pipeline is supported by: The Laboratory Directed Research and Development program of Los Alamos National Laboratory (20200706ER), and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Interagency Agreement No. AAI12007-001-00000.


GISAID data provided on this website is subject to GISAID’s Terms and Conditions

Questions or comments? Contact us at seq-info@lanl.gov

 
Operated by Triad National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration
© Copyright Triad National Security, LLC. All Rights Reserved | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health